Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis

Yun Zhang(Duke Medical Center), Robert A. Weinberg(Whitehead Institute for Biomedical Research), Nathan A. Lack(Koç University), Mehreen Ali Khan(National Institute Of Blood Disease and Bone Marrow Transplantation), Jordan A. Krall(Casma Therapeutics (United States)), Ferenc Reinhardt(Whitehead Institute for Biomedical Research), Michael Tyler(Georg Speyer Haus), Tamer T. Önder(Koç University), Sunny Das(Whitehead Institute for Biomedical Research), Aviv Regev(Broad Institute), Heather R. Keys(Whitehead Institute for Biomedical Research), Matan Hofree(Broad Institute), Joana Liu Donaher(Whitehead Institute for Biomedical Research), Prathapan Thiru(Whitehead Institute for Biomedical Research), Tugba Bagcı-Önder(Koç University), Molly M. Wilson(Massachusetts Institute of Technology), Arthur W. Lambert(AstraZeneca (South Korea)), Jacqueline A. Lees(Massachusetts Institute of Technology), Xin Li(Hubei University of Medicine), Ozlem Yedier-Bayram(Koç University), Itay Tirosh(Weizmann Institute of Science)
Nature Cell Biology
April 1, 2022
Cited by 130


Related Papers